Adult Giant Cell Glioblastoma Completed Phase 1 / 2 Trials for Cediranib (DB04849)

IndicationStatusPhase
DBCOND0028733 (Adult Giant Cell Glioblastoma)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00662506Cediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed GlioblastomaTreatment